Compounds > carbamates
Page last updated: 2024-10-16

carbamates and Hypertension, Malignant

carbamates has been researched along with Hypertension, Malignant in 2 studies

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavesi, V1
Campus, G1
Repetto, S1
Rezzonico, A1
Gervasini, N1

Other Studies

2 other studies available for carbamates and Hypertension, Malignant

ArticleYear
[Results of hypotensive treatment in a hospital environment].
    Minerva medica, 1968, May-19, Volume: 59, Issue:40

    Topics: Adult; Aged; Arteriosclerosis; Carbamates; Female; Humans; Hydralazine; Hydrochlorothiazide; Hyperte

1968
[Considerations on ambulatory therapy in a group of hypertensive patients].
    Minerva medica, 1969, Jun-27, Volume: 60, Issue:51

    Topics: Adult; Aged; Ambulatory Care; Carbamates; Female; Guanethidine; Humans; Hydralazine; Hydrochlorothia

1969